ノロウイルス・ワクチンの世界市場機会分析...市場調査レポートについてご紹介

【英文タイトル】MarketVIEW: Norovirus vaccines - Global vaccine commercial opportunity assessment

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

※レポート紹介PDF⇒http://www.vaczine-analytics.com/VAMV015_TOC_151012.pdf

****This product is composed of a model and summary presentation

Contents – Summary presentation (MS PowerPoint based)
Authors note
Contents
Executive summary
Commercial model: key outputs
Norovirus vaccines: global value ($m) to 2035 per segment
Norovirus vaccines: global value ($m) to 2035 per scenario
Norovirus vaccines: global volume (doses) to 2035 per segment
Key model parameters:
Key model parameters: scenario definitions
Forecast comparisons: June 2010 vs. October 2015
The role of a norovirus vaccine
Norovirus vaccines: target product profile
Potential markets for norovirus vaccines: LTCFs
Potential markets for norovirus vaccines: infants
Potential markets for norovirus vaccines: cruise ship passengers
Potential markets for norovirus vaccines: passenger growth
Potential markets for norovirus vaccines: HCWs
Pricing
Norovirus: background and epidemiology
Norovirus: media coverage
The pathogen
Norovirus: genogroup classifications
Disease burden
Norovirus and diarrheal disease worldwide
Estimates of annual burden (US)
Impact in Infants
Infants: US hospitalization rates
NoV incidence and infection from a birth cohort in a Peruvian community
Cruise ships and norovirus
Cruise ships: norovirus outbreaks
Long-term care facilities and norovirus
Long-term care facilities: comparison to other settings
Healthcare settings
Challenges with estimating norovirus disease burden
Norovirus and diagnostics
Norovirus and subclinical disease
Norovirus and chronic health consequences
Norovirus infection and genetic susceptibility
Norovirus vaccines: background and rationale
Stakeholder messages: need for vaccines
Natural immunity to norovirus
The role of a norovirus vaccine
Norovirus vaccines: target product profile
Target group considerations for a norovirus vaccine
Norovirus: correlates of immune protection
Challenges to norovirus vaccine development50
Norovirus vaccines: R&D pipeline
Development status of current vaccine candidates
Norovirus vaccine pipeline: Takeda
Takeda GI.1, GII.4 cVLP: Phase I results
Takeda GI.1, GII.4 cVLP: Phase II results
Takeda: ongoing Phase II program
Takeda: duration of protection
Norovirus vaccine pipeline: Takeda
Norovirus vaccine pipeline: Phase II results
Norovirus vaccine pipeline: other vaccines
Bibliography
About VacZine Analytics
Disclaimer

*** PAGES: 64 MS PowerPoint slides, fully referenced/sourced. Available in .pdf form

Contents – Vaccine demand model (MS Excel-based)
Title sheet
Charts
VALUE SUMMARY – total market
VOLUME SUMMARY – total market
US lo/base/hi
Canada lo/base/hi
UK lo/base/hi
France lo/base/hi
Germany lo/base/hi
Italy lo/base/hi
Spain lo/base/hi
EU other lo/base/hi
Australia lo/base/hi
Total population
Births
>65 yrs
Pricing summary
Pub/priv split
Cruise ship passengers
Cruise ship outbreaks
HCWs
Pipeline
Country income group
Disclaimer
BACK PAGE

*** WORKSHEETS: ~25


【レポート販売概要】

■ タイトル:ノロウイルス・ワクチンの世界市場機会分析
■ 英文:MarketVIEW: Norovirus vaccines - Global vaccine commercial opportunity assessment
■ 発行日:2015年10月
■ 調査会社:VacZine Analytics
■ 商品コード:VACZ51102
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。